HT Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.27M Hold
12,860
0.9% 15
2026
Q1
$3.14M Sell
12,860
-166
-1% -$38.7K 0.95% 15
2025
Q4
$2.7M Hold
13,026
0.8% 16
2025
Q3
$2.42M Sell
13,026
-244
-2% -$41.8K 0.74% 18
2025
Q2
$2.03M Sell
13,270
-250
-2% -$38.4K 0.62% 18
2025
Q1
$2.24M Sell
13,520
-411
-3% -$64.3K 0.77% 16
2024
Q4
$2.01M Sell
13,931
-95
-0.7% -$14.7K 0.69% 18
2024
Q3
$2.27M Hold
14,026
0.8% 14
2024
Q2
$2.05M Sell
14,026
-288
-2% -$42.8K 0.72% 16
2024
Q1
$2.26M Sell
14,314
-60
-0.4% -$9.55K 0.82% 13
2023
Q4
$2.25M Hold
14,374
0.9% 12
2023
Q3
$2.24M Hold
14,374
0.67% 16
2023
Q2
$2.38M Sell
14,374
-183
-1% -$29.5K 0.69% 17
2023
Q1
$2.26M Sell
14,557
-625
-4% -$101K 0.67% 16
2022
Q4
$2.68M Buy
15,182
+159
+1% +$27.5K 0.88% 14
2022
Q3
$2.45M Buy
15,023
+358
+2% +$60.6K 1.05% 9
2022
Q2
$2.6M Buy
14,665
+26
+0.2% +$4.63K 1.04% 10
2022
Q1
$2.59M Sell
14,639
-175
-1% -$29.8K 0.8% 15
2021
Q4
$2.53M Sell
14,814
-1,005
-6% -$165K 0.74% 15
2021
Q3
$2.56M Hold
15,819
0.78% 15
2021
Q2
$2.61M Sell
15,819
-11
-0.1% -$1.82K 0.8% 14
2021
Q1
$2.6M Buy
15,830
+379
+2% +$61.3K 0.86% 14
2020
Q4
$2.43M Buy
15,451
+323
+2% +$47.7K 0.82% 14
2020
Q3
$2.25M Buy
15,128
+91
+0.6% +$13.5K 0.86% 13
2020
Q2
$2.12M Buy
15,037
+188
+1% +$27.4K 0.85% 13
2020
Q1
$1.95M Buy
14,849
+368
+3% +$52.2K 0.89% 13
2019
Q4
$2.11M Sell
14,481
-879
-6% -$119K 0.84% 10
2019
Q3
$1.99M Buy
15,360
+217
+1% +$28.6K 0.84% 10
2019
Q2
$2.11M Buy
15,143
+264
+2% +$36.5K 0.89% 10
2019
Q1
$2.08M Buy
14,879
+22
+0.1% +$2.95K 0.9% 10
2018
Q4
$1.92M Buy
14,857
+1,858
+14% +$259K 0.92% 10
2018
Q3
$1.81M Buy
12,999
+4,275
+49% +$568K 0.72% 9
2018
Q2
$1.07M Hold
8,724
0.44% 10
2018
Q1
$1.12M Buy
8,724
+200
+2% +$27K 0.46% 10
2017
Q4
$1.19M Sell
8,524
-37
-0.4% -$5.15K 0.48% 10
2017
Q3
$1.12M Sell
8,561
-38
-0.4% -$5.04K 0.49% 10
2017
Q2
$1.14M Sell
8,599
-23
-0.3% -$2.93K 0.51% 10
2017
Q1
$1.07M Buy
8,622
+88
+1% +$10.5K 0.5% 10
2016
Q4
$983K Hold
8,534
0.52% 9
2016
Q3
$1.01M Sell
8,534
-191
-2% -$23.2K 0.58% 9
2016
Q2
$1.06M Sell
8,725
-200
-2% -$22.7K 0.57% 10
2016
Q1
$963K Sell
8,925
-5,217
-37% -$540K 0.56% 10
2015
Q4
$1.41M Buy
14,142
+82
+0.6% +$8.25K 0.91% 22
2015
Q3
$1.3M Sell
14,060
-384
-3% -$37.1K 0.87% 13
2015
Q2
$1.42M Sell
14,444
-464
-3% -$46.5K 0.77% 26
2015
Q1
$1.48M Sell
14,908
-105,063
-88% -$10.7M 0.8% 24
2014
Q4
$12.5M Sell
119,971
-6,723
-5% -$708K 7.91% 3
2014
Q3
$13.2M Sell
126,694
-5,383
-4% -$558K 6.69% 10
2014
Q2
$14M Sell
132,077
-944
-0.7% -$95.4K 7.29% 3
2014
Q1
$13.1M Sell
133,021
-26,492
-17% -$2.46M 8.54% 8
2013
Q4
$14.6M Sell
159,513
-3,949
-2% -$364K 9.33% 2
2013
Q3
$14.2M Sell
163,462
-20,316
-11% -$1.82M 9.16% 2
2013
Q2
$15.8M Buy
+183,778
New +$15.6M 13.46% 1

Other funds holding JNJ

HT Partners's JNJ Position: Q2 2026 in Review

HT Partners held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 12,860 shares worth $3.27M. The position accounts for 0.9% of the portfolio, ranked #15.

HT Partners first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $15.8M in Q2 2013. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • HT Partners held 12,860 shares of Johnson & Johnson worth $3.27M as of Q2 2026.
  • HT Partners left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 0.9% of HT Partners's portfolio in Q2 2026, its #15 holding.
  • HT Partners first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • HT Partners's Johnson & Johnson position peaked at $15.8M in Q2 2013.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on HT Partners's 13F filing for Q2 2026, filed 16 Jul 2026.